Wanhai Medical Instruments Co., Ltd. is a leading solution provider and manufacturer of injection systems for self-medication located in Changzhou City Jiangsu Province China. With a plant area of 12000 square meters, Wanhai Medical's business covers more than 20 countries and regions, we are supplying our products and services to dozens of well-known pharmaceutical companies all over the world. Wanhai Medical is focusing on developing and manufacturing high-quality reusable and disposable(prefilled) pens and auto-injectors. Our injection devices are ideally designed for use with insulin, peptides, other hormone-based therapies, and monoclonal antibody therapy such as Human Growth Hormone (HGH), Glucagon-Like Peptide-1 (GLP-1, Liraglutide, Exenatide, Dulaglutide, Semaglutide)...
Recombinant Human Insulin, Insulin Aspart, Insulin Glargine, Insulin Degludec, Insulin Lispro, etc
Widely used in the monoclonal antibody drugs that packed by prefilled syringe for the treatment of anti-tumor, chronic disease, autoimmune diseases.
Glucagon-Like Peptide-1 (GLP-1), i.e. Liraglutide, Exenatide, Dulaglutide, Semaglutide, etc.
Growth Hormone (GH), Follicle-Stimulating Hormone (FSH) Parathyroid Hormone (PTH) , Etc.
